Conference abstract · 3 Apr 2023
Byline
A. Abati
Articles whose byline reads A. Abati, printed most often as Adeyemi A Abati, Adeyemi Adeniyi Abati, Abati A, Adeyemi Abati and Ayoola Samuel Abati. Different authors can share a byline.
- Articles
- 24
- Latest year
- 2023
Articles
Newest first. Showing 1–24 of 24 articles.
Conference abstract · 17 Nov 2022
Hepatitis c virus testing and treatment among persons receiving buprenorphine in an office - based program for opioid use disorder in Nigeria
Short communication · 28 May 2021
Hepatitis C virus testing and treatment among persons receiving buprenorphine in an office based program for opioid use disorder in Nigeria- Adeyemi A Abati- Lagos University Teaching Hospital
Short communication · 29 Jul 2020
Hepatitis C virus testing and treatment among persons receiving Buprenorphine in an office-based program for opioid use disorders in Nigeria
Conference abstract · 2019
Hepatitis C virus testing and treatment among persons receiving buprenorphine in an office based program for opioid use disorder in Nigeria
Conference abstract · 2019
Hepatitis C virus testing and treatment among persons receiving Buprenorphine in an office-based program for opiod use disorder in Nigeria
Conference abstract · 2019
Hepatitis C infection testing and treatment among people accepting Buprenorphine in an office-based program for narcotic use issue in Nigeria
Conference abstract · 12 Nov 2018
Hepatitis c virus testing and treatment among persons receiving buprenorphine in an office -based program for opioid use disorders in nigeria
Conference abstract · 13 Sep 2018
Hepatitis C virus testing and treatment among persons receiving buprenorphine in an office - based program for opioid use disorders in Nigeria
Conference abstract · 13 Sep 2018
Hepatitis C virus testing and treatment among persons receiving buprenorphine in an office - based program for opioid use disorders in Nigeria
Conference abstract · 29 Aug 2018
Hepatitis C virus testing and treatment among persons receiving Buprenorphine in an office-based program for opioid use disorders in Nigeria
Conference abstract · 16 Aug 2018
Hepatitis c virus testing and treatment among persons receiving buprenorphine in an office-based program for opioid use disorders in Nigeria
Conference abstract · 16 Aug 2018
Hepatitis C virus testing and treatment among persons receiving buprenorphine in an office - based program for opioid use disorders in Nigeria
Conference abstract · 23 Jul 2018
Hepatitis C Virus Testing and Treatment among Persons Receiving Buprenorphine In An Office -Based Program For Opioid Use Disorders In Nigeria
Conference abstract · 2 Jul 2018
Hepatitis C virus testing and treatment among persons receiving buprenorphine
Conference abstract · 25 Jun 2018
Hepatitis C Virus Testing and Treatment among persons receiving Buprenorphine in an office -based program for opioid use disorders in Nigeria
Conference abstract · 28 May 2018
Hepatitis C Virus Testing And Treatment Among Persons Receiving Buprenorphine In An Office -Based Program For Opioid Use Disorders In Nigeria
Conference abstract · 11 May 2018
Hepatitis c virus testing and treatment among persons receiving buprenorphine in an office -based program for opioid use disorders in Nigeria
Conference abstract · 11 May 2018
Hepatitis C virus testing and treatment among persons receiving Buprenorphine in an office-based program for opioid use disorders in Nigeria
Conference abstract · 1 Mar 2018
The EU public health impact of Campylobacter spp. human infection and the EU control strategy in the poultry meat sector
Conference abstract · 2018
Public Health Congress 2018: Hepatitis C Virus testing and treatment among persons receiving Buprenorphine in an office-based program for opioid use disorders in Nigeria - Ayoola Samuel Abati - Lagos University Teaching Hospital
Conference abstract · 23 Oct 2017
Hepatitis C virus testing and treatment among persons receiving buprenorphine in an office-based program for opioid use disorders in Nigeria
Conference abstract
Hepatitis C virus testing and treatment among persons receiving Buprenorphine in an office based program for opioid use disorders in Nigeria
Conference abstract

